IBDEI1F3 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22924,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Intrapelvic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22924,1,4,0)
 ;;=4^C85.16
 ;;^UTILITY(U,$J,358.3,22924,2)
 ;;=^5001707
 ;;^UTILITY(U,$J,358.3,22925,0)
 ;;=C85.12^^76^987^7
 ;;^UTILITY(U,$J,358.3,22925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22925,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Intrathoracic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22925,1,4,0)
 ;;=4^C85.12
 ;;^UTILITY(U,$J,358.3,22925,2)
 ;;=^5001703
 ;;^UTILITY(U,$J,358.3,22926,0)
 ;;=C85.14^^76^987^1
 ;;^UTILITY(U,$J,358.3,22926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22926,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Axilla/Upper Limb Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22926,1,4,0)
 ;;=4^C85.14
 ;;^UTILITY(U,$J,358.3,22926,2)
 ;;=^5001705
 ;;^UTILITY(U,$J,358.3,22927,0)
 ;;=C85.11^^76^987^3
 ;;^UTILITY(U,$J,358.3,22927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22927,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Head/Face/Neck Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22927,1,4,0)
 ;;=4^C85.11
 ;;^UTILITY(U,$J,358.3,22927,2)
 ;;=^5001702
 ;;^UTILITY(U,$J,358.3,22928,0)
 ;;=C85.15^^76^987^4
 ;;^UTILITY(U,$J,358.3,22928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22928,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Inguinal Region/LE Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22928,1,4,0)
 ;;=4^C85.15
 ;;^UTILITY(U,$J,358.3,22928,2)
 ;;=^5001706
 ;;^UTILITY(U,$J,358.3,22929,0)
 ;;=C85.18^^76^987^8
 ;;^UTILITY(U,$J,358.3,22929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22929,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Multiple Site Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22929,1,4,0)
 ;;=4^C85.18
 ;;^UTILITY(U,$J,358.3,22929,2)
 ;;=^5001709
 ;;^UTILITY(U,$J,358.3,22930,0)
 ;;=C85.17^^76^987^9
 ;;^UTILITY(U,$J,358.3,22930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22930,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Spleen
 ;;^UTILITY(U,$J,358.3,22930,1,4,0)
 ;;=4^C85.17
 ;;^UTILITY(U,$J,358.3,22930,2)
 ;;=^5001708
 ;;^UTILITY(U,$J,358.3,22931,0)
 ;;=C85.10^^76^987^10
 ;;^UTILITY(U,$J,358.3,22931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22931,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,22931,1,4,0)
 ;;=4^C85.10
 ;;^UTILITY(U,$J,358.3,22931,2)
 ;;=^5001701
 ;;^UTILITY(U,$J,358.3,22932,0)
 ;;=L60.1^^76^988^2
 ;;^UTILITY(U,$J,358.3,22932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22932,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,22932,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,22932,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,22933,0)
 ;;=L60.2^^76^988^1
 ;;^UTILITY(U,$J,358.3,22933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22933,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,22933,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,22933,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,22934,0)
 ;;=B35.1^^76^988^3
 ;;^UTILITY(U,$J,358.3,22934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22934,1,3,0)
 ;;=3^Onychomycosis
 ;;^UTILITY(U,$J,358.3,22934,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,22934,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,22935,0)
 ;;=L60.3^^76^988^4
 ;;^UTILITY(U,$J,358.3,22935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22935,1,3,0)
 ;;=3^Onychorrexis/Onychodystrophy
 ;;^UTILITY(U,$J,358.3,22935,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,22935,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,22936,0)
 ;;=L50.8^^76^989^4
 ;;^UTILITY(U,$J,358.3,22936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22936,1,3,0)
 ;;=3^Urticaria,Other Spec
